190 related articles for article (PubMed ID: 33634849)
1. Intrauterine device use and risk of ovarian cancer: Results from the New England Case-Control study and Nurses' Health Studies.
Yang J; Sasamoto N; Babic A; Vitonis AF; Townsend MK; Titus L; Cramer DW; Tworoger SS; Terry KL
Int J Cancer; 2021 Jul; 149(1):75-83. PubMed ID: 33634849
[TBL] [Abstract][Full Text] [Related]
2. Ever-use of the intra-uterine device and the risk of ovarian cancer.
Balayla J; Gil Y; Lasry A; Mitric C
J Obstet Gynaecol; 2021 Aug; 41(6):848-853. PubMed ID: 33045859
[TBL] [Abstract][Full Text] [Related]
3. Association of Analgesic Use With Risk of Ovarian Cancer in the Nurses' Health Studies.
Barnard ME; Poole EM; Curhan GC; Eliassen AH; Rosner BA; Terry KL; Tworoger SS
JAMA Oncol; 2018 Dec; 4(12):1675-1682. PubMed ID: 30286239
[TBL] [Abstract][Full Text] [Related]
4. Hormonal and reproductive risk factors for epithelial ovarian cancer by tumor aggressiveness.
Poole EM; Merritt MA; Jordan SJ; Yang HP; Hankinson SE; Park Y; Rosner B; Webb PM; Cramer DW; Wentzensen N; Terry KL; Tworoger SS
Cancer Epidemiol Biomarkers Prev; 2013 Mar; 22(3):429-37. PubMed ID: 23307531
[TBL] [Abstract][Full Text] [Related]
5. Association of oral contraceptive use, other contraceptive methods, and infertility with ovarian cancer risk.
Tworoger SS; Fairfield KM; Colditz GA; Rosner BA; Hankinson SE
Am J Epidemiol; 2007 Oct; 166(8):894-901. PubMed ID: 17656616
[TBL] [Abstract][Full Text] [Related]
6. Contraceptive methods and ovarian cancer risk among Chinese women: A report from the Shanghai Women's Health Study.
Huang Z; Gao Y; Wen W; Li H; Zheng W; Shu XO; Beeghly-Fadiel A
Int J Cancer; 2015 Aug; 137(3):607-14. PubMed ID: 25556333
[TBL] [Abstract][Full Text] [Related]
7. Migraine and invasive epithelial ovarian cancer risk in the Nurses' Health Study II and the Women's Health Study.
Rice MS; Rist PM; Winter AC; Kurth T; Tworoger SS
Int J Cancer; 2018 Feb; 142(3):534-539. PubMed ID: 28929486
[TBL] [Abstract][Full Text] [Related]
8. Pre-diagnosis and post-diagnosis use of common analgesics and ovarian cancer prognosis (NHS/NHSII): a cohort study.
Merritt MA; Rice MS; Barnard ME; Hankinson SE; Matulonis UA; Poole EM; Tworoger SS
Lancet Oncol; 2018 Aug; 19(8):1107-1116. PubMed ID: 30029888
[TBL] [Abstract][Full Text] [Related]
9. Rotating night shift work and risk of ovarian cancer.
Poole EM; Schernhammer ES; Tworoger SS
Cancer Epidemiol Biomarkers Prev; 2011 May; 20(5):934-8. PubMed ID: 21467237
[TBL] [Abstract][Full Text] [Related]
10. Hypertension, use of antihypertensive medications, and risk of epithelial ovarian cancer.
Huang T; Poole EM; Eliassen AH; Okereke OI; Kubzansky LD; Sood AK; Forman JP; Tworoger SS
Int J Cancer; 2016 Jul; 139(2):291-9. PubMed ID: 26934358
[TBL] [Abstract][Full Text] [Related]
11. Coffee intake, variants in genes involved in caffeine metabolism, and the risk of epithelial ovarian cancer.
Kotsopoulos J; Vitonis AF; Terry KL; De Vivo I; Cramer DW; Hankinson SE; Tworoger SS
Cancer Causes Control; 2009 Apr; 20(3):335-44. PubMed ID: 18941913
[TBL] [Abstract][Full Text] [Related]
12. Adult dietary fat intake and ovarian cancer risk.
Rice MS; Poole EM; Willett WC; Tworoger SS
Int J Cancer; 2020 May; 146(10):2756-2772. PubMed ID: 31443135
[TBL] [Abstract][Full Text] [Related]
13. The association of resistance training with risk of ovarian cancer.
Buras AL; Hathaway CA; Wang T; Townsend MK; Tworoger SS
Cancer Med; 2021 Apr; 10(7):2489-2495. PubMed ID: 33704932
[TBL] [Abstract][Full Text] [Related]
14. Anthropometric measures and risk of epithelial ovarian cancer: results from the nurses' health study.
Kotsopoulos J; Baer HJ; Tworoger SS
Obesity (Silver Spring); 2010 Aug; 18(8):1625-31. PubMed ID: 20035276
[TBL] [Abstract][Full Text] [Related]
15. Polymorphisms in the vitamin D receptor and risk of ovarian cancer in four studies.
Tworoger SS; Gates MA; Lee IM; Buring JE; Titus-Ernstoff L; Cramer D; Hankinson SE
Cancer Res; 2009 Mar; 69(5):1885-91. PubMed ID: 19223536
[TBL] [Abstract][Full Text] [Related]
16. Plasma 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D and risk of incident ovarian cancer.
Tworoger SS; Lee IM; Buring JE; Rosner B; Hollis BW; Hankinson SE
Cancer Epidemiol Biomarkers Prev; 2007 Apr; 16(4):783-8. PubMed ID: 17416771
[TBL] [Abstract][Full Text] [Related]
17. A prospective study of phobic anxiety, risk of ovarian cancer, and survival among patients.
Poole EM; Kubzansky LD; Sood AK; Okereke OI; Tworoger SS
Cancer Causes Control; 2016 May; 27(5):661-8. PubMed ID: 27023470
[TBL] [Abstract][Full Text] [Related]
18. Plasma androgen concentrations and risk of incident ovarian cancer.
Tworoger SS; Lee IM; Buring JE; Hankinson SE
Am J Epidemiol; 2008 Jan; 167(2):211-8. PubMed ID: 17982156
[TBL] [Abstract][Full Text] [Related]
19. Body size in early life and risk of epithelial ovarian cancer: results from the Nurses' Health Studies.
Baer HJ; Hankinson SE; Tworoger SS
Br J Cancer; 2008 Dec; 99(11):1916-22. PubMed ID: 19034283
[TBL] [Abstract][Full Text] [Related]
20. Intrauterine Device Use and Ovarian Cancer Risk: A Systematic Review and Meta-analysis.
Wheeler LJ; Desanto K; Teal SB; Sheeder J; Guntupalli SR
Obstet Gynecol; 2019 Oct; 134(4):791-800. PubMed ID: 31503144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
